Rheumatoid Arthritis Completed Phase Trials for Infliximab (DB00065)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

DBCOND0027961 (Rheumatoid Arthritis)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00727298Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)
NCT00748826Remicade Safety Line (Study P03236)(COMPLETED)
NCT02605642Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade
NCT03496831Predicting Hospitalized Infection in Patients With Chronic Inflammatory Arthritis Treated With Biological Drugs
NCT00948610Sleep and Immunity in Rheumatoid Arthritis : Remicade SubstudyBasic Science
NCT01592292An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy
NCT00725621Real Life Dosing of Remicade for Rheumatoid Arthritis in Austria Monitored Over 9 Infusions (Study P03756)(COMPLETED)
NCT00724243Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED)
NCT00705289A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250)
NCT00840957Pharmaco Kinetic Variability of Infliximab in Rheumatoid Arthritis
NCT00901550The Chinese University of Hong Kong Early Arthritis StudyTreatment